Transcript Slide 1

Cross-interference of RLR and TLR signaling
pathways modulates antibacterial T cell
responses
Hideo Negishi, Hideyuki Yanai, Akira Nakajima, Ryuji Koshiba,
Koji Atarashi, Atsushi Matsuda, Kosuke Matsuki, Shoji Miki,
Takahiro Doi, Alan Aderem, Junko Nishio, Stephen T Smale,
Kenya Honda & Tadatsugu Taniguchi
Nature Immunology volume 13 7 July 2012 p659
Pathogen Pattern Recognition
Receptors (PPRR)
Bind Pathogen Associated Molecular
Pattern (PAMP) molecules.
1. MBP and C-RP are soluble PPRR
2. TLR and LPS-BP are membrane-bound PPRR
3. NLR (Nod-like receptor) and RLH (Rig-like
Helicase) are cytoplasmic PPRR
Viral infection (VSV) increases
susceptibility to bacterial infection
(LM).
Negishi Hideo et al. (2012) Figure Suppl 6a
Negishi Hideo et al. (2012) Figure Suppl 6b
Different cytokine gene profiles
induced (expressed) by RLRs and
TLRs.
Stimulation with CpG (bacterial-DNA)
Negishi Hideo et al. (2012) Figure 1a
Stimulation with B-DNA (virus infection)
Imiquimod (R-837) stimulates TLR-7
Quantitative RT-PCR.
Negishi Hideo et al. (2012) Figure 1b
ELISA
Negishi Hideo et al. (2012) Figure Suppl. 1d
Listeria monocytogenes
Klebsiella pneumoniae
Escherichia coli
Salmonella typhimurium
Vesicular Stomatitis Virus
Newcastle Disease Virus
Negishi Hideo et al. (2012) Figure 1c
Selective suppression of TLRinduced Il12b by RLR signaling.
Negishi Hideo et al. (2012) Figure 1d
Caption of Figure 1:
“Data are representative of three
experiments (mean and s.d. of
triplicates in b–d).”
“… simultaneous stimulation of RLRs and TLRs also
resulted in considerable suppression of the expression of
Il12b mRNA (Supplementary Fig. 2b).”
Negishi Hideo et al. (2012) Figure Supp. 2b
Virus-induced interferon exerts anti-viral activity by inhibiting protein
synthesis in neighboring cells. Thus, it is plausible that the decrease in Il12
upon virus infection (RLR stimulation) resulted from the generalized
inhibition of protein synthesis by interferon.
Virus
Interferon
RLR
Inhibition of protein
synthesis
Interferon
receptor
INFaR1-deficient cells
Negishi Hideo et al. (2012) Figure Suppl 2d
WT cells
Negishi Hideo et al. (2012) Figure 1d
INFaR deficient
Negishi Hideo et al. (2012) Figure Suppl. 2d
WT cells
Cycloheximide
treatment
Negishi Hideo et al. (2012) Figure Suppl 2e
Suppressive effect of IRF3 on
the Il12b promotor.
IRF-RE
Negishi Hideo et al. (2012) Figure 2a
Chip assay (Chromatin immunoprecipitation)
[poly(I:C) stimulation; Il12b promotor]
Negishi Hideo et al. (2012) Figure 2b
Negishi Hideo et al. (2012) Figure 2c
Negishi Hideo (2012)
Figure suppl. 3a
Chip assay (Chromatin immunoprecipitation)
[poly(I:C) stimulation; Infb1 promotor]
Negishi Hideo et al. (2012) Figure Suppl. 3b
ChIP assay.
[Il12b promotor in WT and IRF3-/- cells;
Poly (I:C) stimulation]
Negishi Hideo et al. (2012) Figure 3a
Negishi Hideo et al. (2012) Figure 3b
Microarray. Induction of gene expression by VSV
infection of WT and IRF3 -/- macrophages.
Negishi Hideo et al. (2012) Figure Suppl 3f
Negishi Hideo et al. (2012) Figure 3c
Negishi Hideo et al. (2012) Figure 3d
Negishi Hideo et al. (2012) Figure 3e
Binding of Transcription Factors to Il12b promotor
by LPS AFTER stimulation with poly(I:C)
Negishi Hideo et al. (2012) Figure 4a
Negishi Hideo et al. (2012) Figure 4b
Negishi Hideo et al. (2012) Figure 4c
Dominant effect of IRF3 over IRF5 on
the Il12b promotor.
Activation of IRF-3 with different TLR- and RLR-inducers.
(Native PAGE)
(SDS PAGE)
Western blot followed by
immunostaining.
Negishi Hideo et al. (2012) Figure 5a
Plasmid
coding for
IRF-3-5D
IRF-3
Plasmid coding for
IL-12b promotor
5’ of Luciferase gene
Luciferase
gene
Promotor
Luciferase Reporter Assay
Plasmid coding for
Infb promotor
5’ of Luciferase gene
Transient luciferase reporter system for
Il12b and INF-b promotor activation.
Negishi Hideo et al. (2012) Figure Suppl 4b
Transient luciferase reporter system: two
ISREs for IRF5 in the Il12b promotor.
Negishi Hideo et al. (2012) Figure Suppl 4d
Active form of IRF3 that
spontaneously undergoes
dimerization
Constitutively
active IRF-5
Negishi Hideo et al. (2012) Figure 5b
Negishi Hideo et al. (2012) Figure 5c
(Dual transfection!!)
Negishi Hideo et al. (2012) Figure Suppl. 4e.
Polarization of CD4+ cells by innate
signaling.
Negishi Hideo et al. (2012) Figure 6a
Eli-spot: Cytokine-producing Th cells.
Negishi Hideo et al. (2012) Figure 6b
Negishi Hideo et al. (2012) Figure Suppl. 5b
Negishi Hideo et al. (2012) Figure 6c
Negishi Hideo et al. (2012) Figure Suppl. 5e
Negishi Hideo et al. (2012) Figure 6d
Attenuation of antibacterial immune
responses by viral infection.
Negishi Hideo et al. (2012) Figure 7a
Negishi Hideo et al. (2012) Figure Suppl 6a
Negishi Hideo et al. (2012) Figure Suppl 6b
Negishi Hideo et al. (2012) Figure 7b
Negishi Hideo et al. (2012) Figure 7c
“VSV + LM had nearly 10,000 fold more bacterial mRNA than LM alone”
Negishi Hideo et al. (2012) Figure 7d
Splenic CD11b+ cells.
IL-12 mRNA measured by qRTPCR and expressed relative to
mRNA of GAPDH gene
Negishi Hideo et al. (2012) Figure 7e
Negishi Hideo et al. (2012) Figure 7f
Negishi Hideo et al. (2012) Figure 7g
Negishi Hideo et al. (2012) Figure 7h
Negishi Hideo et al. (2012) Figure 7i